Page last updated: 2024-09-04

kw 2189 and duocarmycin b2

kw 2189 has been researched along with duocarmycin b2 in 1 studies

Compound Research Comparison

Studies
(kw 2189)
Trials
(kw 2189)
Recent Studies (post-2010)
(kw 2189)
Studies
(duocarmycin b2)
Trials
(duocarmycin b2)
Recent Studies (post-2010) (duocarmycin b2)
10401302

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asada, M; Asai, A; Gomi, K; Hirata, T; Kobayashi, E; Nagamura, S; Okabe, M; Okamoto, A; Saito, H1

Other Studies

1 other study(ies) available for kw 2189 and duocarmycin b2

ArticleYear
Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.
    Cancer research, 1994, May-01, Volume: 54, Issue:9

    Topics: Animals; Antibiotics, Antineoplastic; DNA Damage; DNA, Neoplasm; Drug Screening Assays, Antitumor; Duocarmycins; HeLa Cells; Humans; Indoles; Lethal Dose 50; Male; Mice; Mice, Nude; Pyrrolidinones; Sarcoma 180; Tumor Cells, Cultured

1994